annual CFI:
-$404.08M-$543.96M(-388.86%)Summary
- As of today (June 28, 2025), KYMR annual cash flow from investing activities is -$404.08 million, with the most recent change of -$543.96 million (-388.86%) on December 31, 2024.
- During the last 3 years, KYMR annual CFI has fallen by -$304.24 million (-304.74%).
- KYMR annual CFI is now -388.86% below its all-time high of $139.89 million, reached on December 31, 2023.
Performance
KYMR Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$48.62M-$19.95M(-29.10%)Summary
- As of today (June 28, 2025), KYMR quarterly cash flow from investing activities is $48.62 million, with the most recent change of -$19.95 million (-29.10%) on March 31, 2025.
- Over the past year, KYMR quarterly CFI has increased by +$379.22 million (+114.70%).
- KYMR quarterly CFI is now -40.57% below its all-time high of $81.80 million, reached on June 30, 2022.
Performance
KYMR quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$24.86M+$379.22M(+93.85%)Summary
- As of today (June 28, 2025), KYMR TTM cash flow from investing activities is -$24.86 million, with the most recent change of +$379.22 million (+93.85%) on March 31, 2025.
- Over the past year, KYMR TTM CFI has increased by +$190.45 million (+88.46%).
- KYMR TTM CFI is now -117.77% below its all-time high of $139.89 million, reached on December 31, 2023.
Performance
KYMR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KYMR Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -388.9% | +114.7% | +88.5% |
| 3 y3 years | -304.7% | +88.0% | +79.0% |
| 5 y5 years | -2351.0% | +230.0% | +33.5% |
KYMR Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -388.9% | at low | -40.6% | +114.7% | -117.8% | +94.5% |
| 5 y | 5-year | -388.9% | +4.4% | -40.6% | +114.5% | -117.8% | +94.5% |
| alltime | all time | -388.9% | +4.4% | -40.6% | +114.5% | -117.8% | +94.5% |
KYMR Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $48.62M(-29.1%) | -$24.86M(-93.8%) |
| Dec 2024 | -$404.08M(-388.9%) | $68.57M(-143.5%) | -$404.08M(-10.9%) |
| Sep 2024 | - | -$157.68M(-1108.1%) | -$453.69M(+92.6%) |
| Jun 2024 | - | $15.64M(-104.7%) | -$235.50M(+9.4%) |
| Mar 2024 | - | -$330.61M(-1844.4%) | -$215.31M(-253.9%) |
| Dec 2023 | $139.89M(+581.7%) | $18.95M(-68.7%) | $139.89M(+96.3%) |
| Sep 2023 | - | $60.51M(+68.8%) | $71.27M(-366.7%) |
| Jun 2023 | - | $35.84M(+45.8%) | -$26.72M(-238.9%) |
| Mar 2023 | - | $24.58M(-149.5%) | $19.24M(-6.2%) |
| Dec 2022 | $20.52M | -$49.67M(+32.5%) | $20.52M(+847.3%) |
| Sep 2022 | - | -$37.48M(-145.8%) | $2.17M(-102.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $81.80M(+216.3%) | -$97.22M(-17.8%) |
| Mar 2022 | - | $25.86M(-138.0%) | -$118.30M(+18.5%) |
| Dec 2021 | -$99.83M(-76.4%) | -$68.02M(-50.3%) | -$99.83M(+178.8%) |
| Sep 2021 | - | -$136.86M(-325.4%) | -$35.81M(-84.7%) |
| Jun 2021 | - | $60.72M(+37.0%) | -$233.26M(-31.6%) |
| Mar 2021 | - | $44.32M(-1210.9%) | -$340.86M(-19.3%) |
| Dec 2020 | -$422.59M(+2463.3%) | -$3.99M(-98.8%) | -$422.59M(+1.0%) |
| Sep 2020 | - | -$334.32M(+613.2%) | -$418.60M(+396.7%) |
| Jun 2020 | - | -$46.87M(+25.3%) | -$84.28M(+125.3%) |
| Mar 2020 | - | -$37.40M | -$37.40M |
| Dec 2019 | -$16.49M(+1115.8%) | - | - |
| Dec 2018 | -$1.36M | - | - |
FAQ
- What is Kymera Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Kymera Therapeutics?
- What is Kymera Therapeutics annual CFI year-on-year change?
- What is Kymera Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly CFI year-on-year change?
- What is Kymera Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kymera Therapeutics?
- What is Kymera Therapeutics TTM CFI year-on-year change?
What is Kymera Therapeutics annual cash flow from investing activities?
The current annual CFI of KYMR is -$404.08M
What is the all time high annual CFI for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash flow from investing activities is $139.89M
What is Kymera Therapeutics annual CFI year-on-year change?
Over the past year, KYMR annual cash flow from investing activities has changed by -$543.96M (-388.86%)
What is Kymera Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of KYMR is $48.62M
What is the all time high quarterly CFI for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash flow from investing activities is $81.80M
What is Kymera Therapeutics quarterly CFI year-on-year change?
Over the past year, KYMR quarterly cash flow from investing activities has changed by +$379.22M (+114.70%)
What is Kymera Therapeutics TTM cash flow from investing activities?
The current TTM CFI of KYMR is -$24.86M
What is the all time high TTM CFI for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM cash flow from investing activities is $139.89M
What is Kymera Therapeutics TTM CFI year-on-year change?
Over the past year, KYMR TTM cash flow from investing activities has changed by +$190.45M (+88.46%)